A t least 30% of the world's population is infected with latent Mycobacterium tuberculosis, which will reactivate in some individuals and cause an estimated 1.4 million deaths a year (1) . Significant obstacles in controlling the epidemic result from the chronic nature of M. tuberculosis infection, which necessitates prolonged treatment and generates a large reservoir of latently infected people. This health crisis is exacerbated by the alarming emergence of drug-resistant strains. The inadequacies of present tuberculosis therapies demand the discovery of new agents to treat M. tuberculosis infection, which requires insight into the pathways used by the pathogen to survive in the host. During infection, the host restrains mycobacteria from proliferating by imposing an arsenal of defenses, including oxidative stress, hypoxia, acid stress, genotoxic stress, cell surface stress, and starvation (reviewed in reference 2). Despite this onslaught of attacks, M. tuberculosis is able to persist for the lifetime of the host, indicating that this pathogen has substantial molecular mechanisms to resist hostinflicted damage.
One way bacteria resist stress is via the stringent response. The stringent response is a conserved global stress response in bacteria that involves the production of the hyperphosphorylated guanine nucleotides ppGpp and pppGpp [collectively called (p)ppGpp]. (p)ppGpp metabolism is controlled by Rel/SpoT homolog proteins (RSHs), named for their sequence similarity to RelA and SpoT enzymes in Escherichia coli (3) . The activity of RelA homologs is best characterized during amino acid starvation when an uncharged tRNA enters the A site of the ribosome and stimulates RelA-mediated (p)ppGpp production (4). (p)ppGpp then regulates a number of cellular processes, including transcription, replication, cell surface morphology, and nucleotide levels (reviewed in references 5 and 6).
In M. tuberculosis, the stringent response is initiated by the M. tuberculosis Rel (Rel Mtb ) enzyme, which transfers the 5=-␤,␥-pyrophosphate from ATP to the 3=-OH of GDP or GTP to synthesize ppGpp and pppGpp, respectively (7) . The (p)ppGpp synthetase domain is in the middle of the Rel Mtb protein, and a mutation of a conserved histidine (H344) or glycine (G241) residue in this domain abolishes synthetase activity (8, 9) . The C terminus of Rel Mtb is not required for catalytic activity but is necessary for association with the Rel Mtb activating complex, which consists of ribosomes, mRNA, and tRNAs and regulates (p)ppGpp synthesis (10, 11) . Rel Mtb also hydrolyzes (p)ppGpp into diphosphate pyrophosphate (PP i ) and GDP or GTP via an N-terminal catalytic HD superfamily domain that is distinct from the (p)ppGpp synthetase domain (9) . HD superfamily members are phosphohydrolases with conserved histidine and aspartate residues that are involved in the coordination of divalent cations, which is essential for their activity (12) . Alanine substitution of the conserved histidine (H80) or aspartate (D81) residue in Rel Mtb abolishes hydrolase activity in vitro without affecting (p)ppGpp synthesis (9) . The crystal structure of the Rel Mtb homolog in Streptococcus dysgalactiae subsp. equisimilis, Rel Seq , indicates that at any given time only one enzymatic function is active, thereby preventing simultaneous synthesis and hydrolysis of (p)ppGpp (13) .
M. tuberculosis mutants deleted for the entire rel Mtb gene (⌬rel Mtb ) are compromised for long-term survival in culture (7) and are unable to persist in mouse models of infection (14, 15) . In Mycobacterium smegmatis, deletion of rel Msm causes changes in cellular and colony morphology, decreased long-term survival, and increased sensitivity to nutrient starvation and hypoxia (16) . However, it is still unclear which catalytic activities of Rel Mtb contribute to these diverse phenotypes and what role (p)ppGpp has in these processes. In addition to Rel Mtb , M. tuberculosis also encodes a homolog to a group of RSHs called small alarmone synthetases (SAS), which encode the catalytic domain to produce (p)ppGpp but not the hydrolase domain (3) . The role of the M. tuberculosis SAS, Rv1366, in maintaining (p)ppGpp levels, responding to stress, and virulence has yet to be investigated. In many other bacteria, SAS activity is toxic in the absence of a functional (p)ppGpp hydrolase (17) (18) (19) (20) (21) . If this were the case in M. tuberculosis, Rv1366-mediated (p)ppGpp synthesis in the ⌬rel Mtb strain could be the cause for attenuation of this strain. We have addressed these questions regarding the roles of (p)ppGpp metabolism by studying strains of M. tuberculosis that express alleles of Rel Mtb that are defective in individual catalytic activities and strains deficient in the rv1366 gene.
MATERIALS AND METHODS
M. tuberculosis strains and media. All M. tuberculosis strains were derived from Erdman and were grown planktonically at 37°C in 7H9 (broth) or 7H10 (agar) (Difco) medium supplemented with 10% oleic acid-albumin-dextrose-catalase (OADC), 0.5% glycerol, and 0.05% Tween 80 (broth). Biofilm cultures were grown in 24-well dishes at 37°C by inoculating 1.5 ml of Sauton's medium with 150 l of saturated planktonic culture. The 24-well dish was placed in a tightly sealed Tupperware dish for 3 weeks, at which point the Tupperware was opened and incubated for another week before photographing. This is similar to previously described conditions used to form M. tuberculosis biofilms (22) .
The ⌬rel Mtb strain was made by infecting M. tuberculosis Erdman with a specialized transducing phage (phAE87) containing homology to M. tuberculosis nucleotides 2907267 to 2907826 and 2910191 to 2910844, which replaced all but the first two codons and the stop codon of the endogenous rel Mtb gene with a hygromycin resistance cassette. The ⌬rv1366 strain was made by infecting wild-type (WT) M. tuberculosis Erdman with phAE87 containing homology to M. tuberculosis nucleotides 1537706 to 1538406 and 1539203 to 1539884, which replaced all but the first 6 codons and the last 2 codons of the endogenous rv1366 gene with a hygromycin resistance cassette flanked by two loxP sites. The deletion of rv1366 in this strain was confirmed by EcoRI digestion of genomic DNA and Southern blot analysis using a radiolabeled fragment containing M. tuberculosis nucleotides 1537706 to 1538406 as the probe. The hygromycin resistance cassette was cured from the ⌬rv1366 strain by transforming the strain with an unstable episomal plasmid (pmsg381) that expresses the Cre recombinase. Loss of the hygromycin resistance cassette was confirmed by both PCR and plating in the presence or absence of hygromycin. The rel Mtb gene was deleted from the ⌬rv1366 strain to make the ⌬rel Mtb ⌬rv1366 strain by infecting the ⌬rv1366 strain, which had been cured of the hygromycin resistance cassette, with the phAE87 phage that replaces the endogenous rel Mtb gene with a hygromycin resistance cassette. The deletion of the rel Mtb gene in this strain was confirmed by Southern blot analysis of SmaI-digested genomic DNA using a radiolabeled fragment containing M. tuberculosis nucleotides 2910191 to 2910844 as a probe.
To express the rel Mtb WT , rel Mtb H344Y , rel Mtb H80A , rel Mtb H344Y-H80A , or rv1366 allele from the attB site of the gene deletion strains, the ⌬rel Mtb , ⌬rv1366, or ⌬rel Mtb ⌬rv1366 strain was transformed with a pMSG430 plasmid that integrates into the attB site of the genome, confers kanamycin resistance, and expresses the respective allele from a constitutive pmyc1tetO promoter. Control strains were made by transforming each deletion mutant with an empty pMSG430 vector. The rel Mtb and rv1366 genes from each transformant were sequenced to confirm the presence of the correct sequence. There is only a single copy each of the rel Mtb and rv1366 genes in all strains of mycobacteria used in this paper. Antibiotics. Twenty g/ml kanamycin, 50 g/ml hygromycin, 20 g/ml streptomycin, and 50 ng/ml of anhydrotetracycline (ATc) were used for both mycobacterial species.
Mouse infections. Before infection, exponentially replicating M. tuberculosis bacteria were washed in phosphate-buffered saline (PBS) plus 0.05% Tween 80 and sonicated to disperse clumps. Eight-to 9-week-old female C57BL/6 mice (Jackson Laboratory) were exposed to 8 ϫ 10 7 CFU of the appropriate strain in an inhalation exposure system (Glas-Col), which delivers ϳ100 bacteria to the lung per animal. Bacterial burden was determined by plating serial dilutions of lung and spleen homogenates onto 7H10 agar plates in the absence or presence of kanamycin and streptomycin. Plates were incubated at 37°C in 5% CO 2 for 3 weeks prior to counting colonies. When indicated, the standard diet was replaced with doxycycline-containing mouse chow (2,000 ppm; Research Diets). All procedures involving animals were conducted by following the National Institutes of Health guidelines for housing and care of laboratory animals and were performed in accordance with institutional regulations after protocol review and approval by the Institutional Animal Care and Use Committee of The Washington University in St. Louis School of Medicine (protocol 20100190; Analysis of Mycobacterial Pathogenesis). Washington University is registered as a research facility with the U.S. Department of Agriculture and is fully accredited by the American Association of Accreditation of Laboratory Animal Care. The Animal Welfare Assurance is on file with OPRR-NIH. All animals used in these experiments were subjected to no or minimal discomfort. All mice were euthanized by CO 2 asphyxiation, which is approved by the Panel on Euthanasia of the American Veterinary Association.
qRT-PCR. RNA was extracted from exponentially growing mycobacteria using TRIzol (Invitrogen), cDNA was prepared using Superscript III (Invitrogen), and quantitative reverse transcription-PCR (qRT-PCR) was performed using the Bio-Rad Sso Advanced SYBR green kit. Levels of rel Mtb and rel Msm transcript were normalized to sigA transcript levels as previously described (23) .
Assaying nucleotide and metabolite levels using LC-MS/MS. M. smegmatis Tet-Rel Mtb H80A and control strains were grown to exponential phase and treated with 50 ng/ml ATc for 6 h, and 5.9 ϫ 10 9 CFU per sample was collected and washed in PBS. ATP, GTP, ppGpp, and pppGpp were assayed using a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. For the nucleotide extraction, 10 l of 0.1 mM internal standard Br-ATP was spiked in each sample. Six hundred l of cold 50% ethanol was added to each sample, and samples were homogenized with TissueLyser II for 5 min at a frequency of 20 Hz/s. After centrifugation at 16,000 ϫ g for 5 min at 4°C, the supernatants were transferred to new tubes and the pellets were reextracted as previously described. The second supernatant was combined with the first one and dried down. The pellets were dissolved in water for LC-MS/MS analysis.
The LC-MS/MS system used is composed of a Shimadzu LC system with two Shimadzu solvent delivery pumps (model LC10AD), a Shimadzu integrated controller (SCL10Avp), a Valco two-position diverter valve, and a LEAP CTC PAL autosampler with a 50-l sample loop. This LC system is interfaced with an AB Sciex 4000 QTRAP mass spectrometer equipped with a TurboIonSpray (TIS) electrospray ion source. Source parameters were set as the following: curtain gas, 10 arbitrary units (AU); source gas 1, 50 AU; source gas 2, 50 AU; collision activated dissociation, high; interface heater, on; temperature, 650°C; ionspray voltage, Ϫ4,500. Both quadruples (Q1 and Q3) were set to unit resolution. Analyst software (version 1.4.2) was used to control sample acquisition and data analysis. The 4000 QTRAP mass spectrometer was tuned and calibrated according to the manufacturer's recommendations. Each compound was detected using 3 multiple reaction monitoring (MRM) transitions that were previously optimized using standards described in Table 1 , with the exception of pppGpp, for which no commercial standard is available. Only 2 MRM transitions for pppGpp were used based on the ppGpp standard.
For LC separation, a Synergi 2.5-U Hydro-RP 100A column (100 by 2 mm; Phenomenex) was used at a flow rate of 0.11 ml/min. The gradient started at 100% solvent A (10 mM tributylamine in 5% methanol, pH 4.8), was held for 2 min, and then moved to 20% solvent B (100% methanol) in 2 min. The gradient then increased to 50% solvent B in 33 min. It was finally ramped up to 90% solvent B in 1 min and then ramped back to initial conditions (100% solvent A) in 1 min and reequilibrated for an additional 7 min. For quantification, a series of standard samples containing different concentrations of compounds was prepared. Calibration curves for all of the compounds were achieved by integration of the peak area under the curve of the standards and then normalized to the internal standard Br-ATP.
RESULTS
Rel Mtb -mediated (p)ppGpp synthesis is required for WT rates of growth on solid media and formation of biofilms. Deletion of M. tuberculosis rel Mtb results in slightly slower growth, compromised long-term survival in cultures (7), and an inability to persist in mouse models of infection (14, 15) . rel Mtb encodes two different enzymatic activities, (p)ppGpp synthesis and hydrolysis, and it is unknown if the phenotypes of the ⌬rel Mtb strain result exclusively from the loss of (p)ppGpp production. A Rel Mtb H344Y point mutant is unable to synthesize (p)ppGpp but retains hydrolase activity in vitro (9) . To determine whether Rel Mtb -mediated (p)ppGpp synthesis is specifically important for mycobacteria, we constructed M. tuberculosis strains deleted for the endogenous rel Mtb gene and constitutively expressing either the rel Mtb WT allele or the rel Mtb H344Y synthetase-dead mutant from the attB site of the genome. As previously reported, the M. tuberculosis ⌬rel Mtb mutant grew more slowly than a strain complemented with the rel Mtb WT allele, which is particularly evident on 7H10 solid media ( Fig. 1A ) (7) . Expression of the Rel Mtb H344Y mutant did not fully complement this growth defect, demonstrating that (p)ppGpp synthesis by Rel Mtb is necessary for optimal growth on solid media. A lower growth rate was defined by smaller colony size on 7H10 plates, as illustrated in Fig. 1A at the 10 Ϫ3 and 10 Ϫ4 dilutions. In addition to the slow growth on solid media, we also observed that loss of Rel Mtb -mediated (p)ppGpp synthetase activity resulted in delayed formation of biofilms and pellicles in static liquid cultures (Fig.  1B) . This illustrates another in vitro condition that requires Rel Mtb -mediated (p)ppGpp synthesis. Biofilms may serve as a model for persister cell formation, in that they harbor a larger number of drug-tolerant cells than planktonic M. tuberculosis cultures (22) . Thus, this defect in biofilm formation by the ⌬rel Mtb mutant may be due to the interference of the same pathways necessary to persist in the mouse infection model.
(p)ppGpp synthesis by Rel Mtb is required for chronic infection in mice. M. tuberculosis infection in mice begins with an initial phase of unrestricted bacterial growth termed acute infection. The onset of adaptive immunity stops the bacterial titers from increasing at 3 to 4 weeks postinfection, but bacteria are still able to persist for the lifetime of the mouse. M. tuberculosis ⌬rel Mtb aerosol infection of mice results in normal initial bacterial growth but impaired chronic infection, resulting in less severe gross pathology of the disease ( Fig. 2) mutant phenocopied the null mutant by not persisting in the murine lungs and spleens and causing less tissue pathology than control strains, demonstrating that Rel Mtb (p)ppGpp synthetase activity is required for chronic M. tuberculosis infection (Fig. 2) .
Rv1366 activity does not contribute to phenotypes of a ⌬rel Mtb mutant and is dispensable for pathogenesis in the mouse model of infection. The SAS homolog Rv1366 is a second predicted (p)ppGpp synthetase in M. tuberculosis and could con- 600 and either diluted and plated on 7H10 plates (A) or grown in Sauton's medium in static, biofilmforming conditions in a 24-well dish (B). (A) 7H10 plates were incubated for 3 weeks at 37°C. (B) Biofilms were incubated for 4 weeks at 37°C. The parent strain used is labeled above each photo, and the protein expressed from the attB site is labeled below the photo. tribute to (p)ppGpp metabolism; however, it has yet to be characterized. To investigate the function of Rv1366, we constructed an M. tuberculosis strain deleted for the predicted (p)ppGpp synthetase rv1366 (⌬rv1366 strain) and an M. tuberculosis double mutant of rel Mtb and rv1366 (⌬rel Mtb ⌬rv1366 strain), which were both confirmed by Southern blot analysis ( Fig. 3A and B) , and monitored their growth rate and ability to form biofilms. The ⌬rv1366 mutant did not have a growth defect compared to controls on either solid media or under biofilm conditions ( Fig. 3C  and D) . Additionally, the ⌬rel Mtb ⌬rv1366 double mutant phenocopied the ⌬rel Mtb single mutant on both solid media (data not shown) and under biofilm conditions (Fig. 3D) . Expression of Rel Mtb WT was also able to fully complement the growth and biofilm phenotypes in the ⌬rel Mtb ⌬rv1366 double mutant ( Fig. 3C  and D ). These data demonstrate that Rv1366 does not provide a function necessary for growth in nutrient-rich media or under biofilm conditions regardless of the presence of Rel Mtb -mediated (p)ppGpp synthesis. We then examined whether Rv1366 was necessary during M. tuberculosis infection of mice by infecting C57BL/6 mice with the ⌬rv1366 mutant and the ⌬rel Mtb ⌬rv1366 double mutant. The ⌬rv1366 single mutant was not attenuated during infection in either the lung or the spleen, and the ⌬rel Mtb ⌬rv1366 double mutant phenocopied the ⌬rel Mtb mutant and was fully complemented by expression of only Rel Mtb WT (Fig. 4) . These data show that Rv1366 is not necessary for M. tuberculosis growth or survival in vitro or in vivo in the models tested.
In Bacillus subtilis, the phenotypes of the ⌬relA strain are attributed in part to the absence of (p)ppGpp hydrolase activity in the presence of two SAS homologs, such that suppressors of the B. subtilis ⌬relA mutant have inactivating mutations in the SAS genes (17) . Therefore, we wanted to confirm that the M. tuberculosis rv1366 gene was intact in the ⌬rel Mtb strain. We sequenced rv1366 Rel Mtb hydrolase activity is critical for mycobacterial physiology when (p)ppGpp synthesis is intact. In addition to (p)ppGpp synthesis, Rel Mtb is the only known enzyme in M. tuberculosis that is capable of hydrolyzing (p)ppGpp for turnover and renewal of GTP and GDP by removal of pyrophosphate. In order to investigate the roles of the Rel Mtb hydrolase activity during growth and survival, we attempted to generate strains of M. tuberculosis expressing a single copy of Rel Mtb that was hydrolase dead but retained (p)ppGpp synthetase activity (Rel Mtb . We also constructed a control strain by inserting an empty vector into the attB site of WT M. tuberculosis and transforming this strain with the same TetR-expressing plasmid as that in Tet-Rel Mtb
H80A
. rel Mtb expression from its endogenous locus in the control strain is not affected by ATc (Fig. 5A) . Induction of rel Mtb H80A transcription in the presence of ATc in the Tet-Rel Mtb H80A strain was confirmed by quantitative real-time PCR (qRT-PCR) (Fig. 5A) .
We plated the M. tuberculosis control and Tet-Rel Mtb H80A strains onto 7H10 agar in the absence or presence of ATc and found that although the strains had equivalent survival rates under both conditions, the Tet-Rel Mtb H80A strain exhibited smaller, rounder, and smoother colonies than control bacteria in the presence of ATc (Fig. 5B ). This demonstrates that inducing expression of Rel Mtb H80A , which will synthesize (p)ppGpp but will not hydrolyze (p)ppGpp, has an impact on M. tuberculosis physiology. Thus, (p)ppGpp turnover is required to maintain normal colony morphology. There was a mild effect on colony morphology in the Tet-Rel Mtb H80A strain in the absence of ATc (Fig. 5B) , suggesting that even low levels of rel Mtb H80A expression in the absence of inducer due to the inherent leakiness of the TetR system was enough to affect bacterial physiology. This low level of rel Mtb H80A transcription in the Tet-Rel Mtb H80A strain in the absence of ATc was detectable by qRT-PCR and was close to 100-fold lower than in induced conditions (Fig. 5A) .
We (Fig. 5C ). This demonstrated that the role of (p)ppGpp turnover in colony morphology is conserved in M. tuberculosis and M. smegmatis. Interestingly, when we plated the M. smegmatis Tet-Rel Mtb WT and TetRel Mtb H80A strains on LB agar in the absence or presence of ATc, the induced expression of the rel Mtb H80A mutant allele inhibited growth ( Fig. 5D and E) and all of the Tet-Rel Mtb H80A colonies that grew were no longer responsive to the presence of ATc, as determined by plating and qRT-PCR. Therefore, in order to grow on nutrient-rich LB media, the M. smegmatis Tet-Rel Mtb H80A strain must mutate the Tet-inducible system and permanently repress the expression of rel Mtb H80A to survive. This proved that inhibition of the Rel Mtb (p)ppGpp hydrolase activity in the presence of a functional (p)ppGpp synthetase is toxic to M. smegmatis in nutrient-rich LB media and links nutrient availability with the importance of (p)ppGpp turnover. (p)ppGpp production has been associated with colony morphology in mycobacteria (16, 25) , but this is the first time in mycobacteria that the hydrolysis of (p)ppGpp has been shown to be required for maintenance of WT colony morphology and growth in nutrient-rich conditions.
(p)ppGpp levels were measured in the M. smegmatis TetRel Mtb WT and Tet-Rel Mtb H80A strains by liquid chromatography- tandem mass spectrometry (LC-MS/MS), but because of the low levels of (p)ppGpp in the samples, the measurements observed were not confidently reproduced. However, the same LC-MS/MS approach was used to monitor ATP and GTP levels in LB liquid cultures of M. smegmatis Tet-Rel Mtb WT and Tet-Rel Mtb H80A in the presence and absence of ATc (Fig. 5F ). We found that following induction of rel Mtb H80A expression in M. smegmatis for 6 h, GTP levels were significantly decreased compared to those of strains expressing Rel Mtb WT . Conversely, ATP levels during induction of rel Mtb H80A expression were actually higher than those of control strains. The increased transcription of the rel Mtb H80A gene within 6 h of ATc treatment in the M. smegmatis Tet-Rel Mtb H80A strain was confirmed by qRT-PCR (Fig. 5G ). These data demonstrate that inhibition of (p)ppGpp hydrolysis impacts not only (p)ppGpp levels but also ATP and GTP levels within the bacteria.
Inhibition of Rel Mtb (p)ppGpp hydrolase activity is lethal for acute and chronic M. tuberculosis infection in mice. We next investigated whether inhibition of (p)ppGpp hydrolysis, while keeping (p)ppGpp synthesis intact, would compromise M. tuberculosis pathogenesis. We tested this by infecting mice with either the control M. tuberculosis strain that expresses rel Mtb from its native locus or the Tet-Rel Mtb H80A strain that allows for conditional expression of the rel Mtb H80A allele in the presence of doxycycline. We then determined bacterial titers in the lungs and spleens during both acute and chronic infection (Fig. 6 ). In the absence of doxycycline, control and Tet-Rel Mtb H80A M. tuberculosis strains displayed similar kinetics and virulence in mice (Fig. 6A  and B) . Since both strains express TetR from a plasmid that also confers streptomycin resistance and contain a kanamycin resistant cassette integrated into the attB site that, in the case of TetRel Mtb H80A , carries the rel Mtb H80A allele, we could monitor the retention of the Tet-inducible system during infection. By plating the lung and spleen homogenates on plates containing streptomycin and kanamycin, we showed that the Tet-inducible system was intact for at least 10 weeks postinfection in both strains in the absence of doxycycline (Fig. 6C) . It was surprising that the TetRel Mtb H80A strain was able to maintain high titers during chronic infection, since the levels of rel Mtb H80A transcripts were a log lower than those in the control strain (Fig. 5A) , and we have shown that the absence of rel Mtb expression leads to lower titers during chronic infection (Fig. 2) . This indicated that the low-level leaky expression of the rel Mtb H80A allele in the absence of doxycycline was able to result in enough (p)ppGpp synthesis to phenocopy WT M. tuberculosis instead of the ⌬rel Mtb strain (Fig. 2) but not too much (p)ppGpp synthesis to confer toxicity in the absence of a functional hydrolase. In order to confirm that the low levels of rel Mtb H80A transcription allowed for synthesis of (p)ppGpp in the Tet-Rel Mtb H80A strain in the absence of inducer, we analyzed the ability of this strain to form biofilms, which is a phenotype we had previously shown requires (p)ppGpp synthesis (Fig. 1B) . In the absence of ATc, when only low levels of rel Mtb H80A transcription are occurring, the Tet-Rel Mtb H80A strain was able to form biofilms similar to those observed in WT Rel Mtb -expressing strains, further supporting that the low level of rel Mtb H80A transcription in the absence of inducer is enough to allow for adequate (p)ppGpp synthesis to confer normal bacterial physiology (Fig. 6D) .
Separate groups of mice were infected with either control or Tet-Rel Mtb H80A M. tuberculosis strains and administered doxycycline starting on day 1 (acute infection) (Fig. 6E and F) or day 63 (chronic infection) (Fig. 6G to I) postinfection to determine the effect of inhibiting Rel Mtb (p)ppGpp hydrolase activity during acute and chronic infection in mice. After 1 week of inducing Rel Mtb H80A expression with doxycycline at day 1 postinfection in Tet-Rel Mtb H80A , the bacteria were unable to replicate and decreased in titers to the point that 5 out of 6 animals tested had no detectable M. tuberculosis in the lungs, with a limit of detection of 20 CFU. Additionally, none of the surviving Tet-Rel Mtb H80A cells at day 21 retained the Tet-inducible expression system, as determined by the lack of colony growth from lung homogenates on plates containing streptomycin and kanamycin (Fig. 6F ). In contrast, the control strain that expressed the endogenous rel Mtb allele was not affected by doxycycline treatment at this stage of infection (Fig. 6E) and retained the Tet-inducible expression system (Fig.  6F ). These data demonstrate that even though M. tuberculosis was capable of growth on 7H10 media during inhibition of Rel Mtb (p)ppGpp hydrolase activity (Fig. 5B) , this catalytic activity is essential for acute infection in mice.
During chronic infection, expression of Rel Mtb H80A caused a 2-log decrease of titers in the lungs (Fig. 6G ) and a 1-log decrease in the spleens (Fig. 6H ) over a 4-week period. In the 4 weeks following induction of Rel Mtb H80A expression during chronic infection, 93% of the Tet-Rel Mtb H80A bacteria lost the plasmids encoding the Tet-inducible system and most likely reverted to rel Mtb null by losing the allele and linked kanamycin resistant cassette at the attB site (Fig. 6I ). This would explain why the bacterial titers did not recover after loss of the Tet-inducible system, since an M. tuberculosis ⌬rel Mtb strain is attenuated for chronic infection (Fig.  2 and 6G and H ). These data demonstrate that inhibition of the Rel Mtb (p)ppGpp hydrolase activity in both acute and chronic infection compromises M. tuberculosis survival and presents the Rel Mtb hydrolase domain as a promising drug target. In addition, suppression of the toxic effect of inhibiting the Rel Mtb (p)ppGpp hydrolase activity by losing Rel Mtb -mediated (p)ppGpp synthetase activity still leaves the bacteria unable to persist in the mouse model of infection.
DISCUSSION
A previous study reported that an M. tuberculosis ⌬rel Mtb mutant is attenuated for chronic infection in mice (14) . In the same study, microarray analyses revealed that more than a quarter of the genome was differentially expressed in the ⌬rel Mtb strain in both nutrient-rich and depleted conditions, suggesting that there are extensive metabolic alterations in strains lacking rel Mtb . The transcripts affected included virulence factors, cell wall biosynthetic enzymes, heat shock proteins, and secreted antigens, any of which may contribute to the attenuation in vivo (14) . In addition, WT M. tuberculosis, but not the ⌬rel Mtb mutant, downregulated the cellular translation machinery during nutrient starvation, which is consistent with Rel Mtb 's role in the stringent response and may also be necessary for M. tuberculosis virulence (14) .
Rel Mtb is a large protein encoding two distinct catalytic activities. Despite its importance for pathogenesis, it was still unknown what function(s) of Rel Mtb contribute to its role in vivo. We have dissected the roles of the two enzymatic activities encoded by Rel Mtb during both growth in culture and pathogenesis in mice. By studying a point mutant that specifically abolishes (p)ppGpp synthesis by Rel Mtb , we conclude that (p)ppGpp production by Rel Mtb is required for efficient rates of growth and biofilm formation in culture, as well as for maintaining titers during chronic infection in the mouse model of infection. It is worth noting that we do not have an antibody specific for Rel Mtb ; therefore, we cannot confirm that the Rel Mtb H344Y protein is stably expressed and that the phenotypes are not due to decreased Rel Mtb protein rather than loss of synthetase activity. However, there are multiple lines of evidence that support that it is the loss of synthetase activity, and not protein instability, that results in these phenotypes. First, our group and others are able to purify the mutant protein easily, and it is stable in vitro with no loss in hydrolase activity, suggesting that the protein can fold normally and other domains can function in the presence of the H344Y substitution (9 and data not shown). Second, data presented here indicate that lower levels of Rel Mtb would not phenocopy complete loss of the rel Mtb allele. For instance, infection of mice with the Tet-Rel Mtb H80A strain in the absence of doxycycline, where rel Mtb H80A transcript levels are a log lower than transcripts from the allele in WT M. tuberculosis (Fig. 5A) , indicated that even this low level of synthetase-active Rel Mtb expression is able to sustain WT titers during chronic infection of mice, unlike the ⌬rel Mtb -and Rel Mtb H344Y -expressing strains ( Fig. 2 and 6 ).
(p)ppGpp has been shown to directly impact many processes in other bacteria, including transcription of the translation machinery (26) (27) (28) (29) , GTP and ATP levels (30) (31) (32) (33) , DNA replication (34) (35) (36) (37) , and metabolism (38) (39) (40) . In general, the many effects of (p)ppGpp are complex and seem to vary greatly among different organisms. Any number of these mechanisms may be conserved in mycobacteria, and determining which functions of (p)ppGpp make its production necessary for chronic M. tuberculosis infection requires further study. Since it has been shown that (p)ppGpp accumulates in mycobacteria during starvation (7, 23, 25) , oxidative stress (23) , and stationary phase (7), these would be good conditions to begin to investigate a molecular mechanism for (p)ppGpp in M. tuberculosis.
Our experiments also demonstrate that the production of (p)ppGpp is not the only role of Rel Mtb during pathogenesis. By expressing a rel Mtb point mutant that retains the ability to synthesize (p)ppGpp but is unable to hydrolyze (p)ppGpp, our experiments have highlighted a critical role for Rel Mtb -mediated hydrolysis of (p)ppGpp in colony morphology, survival, and virulence. In contrast to (p)ppGpp synthesis, which is necessary for chronic but not acute infection, hydrolysis of (p)ppGpp is required for all stages of M. tuberculosis infection in mice, suggesting a role for this catalytic activity in general homeostasis. We predict that expression of the Rel Mtb H80A hydrolase mutant leads to increased abundance of (p)ppGpp, which may directly impact cellular pathways in an uncontrolled manner that is detrimental for the bacteria. In addition, we identify a dysregulation of ATP and GTP levels during rel Mtb H80A expression, which also may contribute to the lethality of expressing this allele. A recently published study on B. subtilis highlighted a role for (p)ppGpp in directly inhibiting GTP biosynthesis to maintain GTP levels within a range that supports viability (33) . To investigate whether the phenotypes caused by rel Mtb H80A expression in M. tuberculosis are due to the low levels of GTP, we attempted to increase GTP production by adding guanosine to the media, as was previously done in B. subtilis (33) . Unfortunately, guanosine supplementation did not restore WT GTP levels, colony morphology, or growth rate during Rel Mtb H80A expression in mycobacteria. However, this may be due to inability of the nucleoside to access the mycobacterial cytosol.
Evidence of the importance of controlling (p)ppGpp levels specifically by hydrolysis activity comes from studies of small alarmone synthetase (SAS) homologs in B. subtilis (17, 18) , Streptomyces mutans (19) , Enterococcus faecalis (20) , and Vibrio cholerae (21) . SAS proteins encode the catalytic domain to produce (p)ppGpp but not the domain to hydrolyze it. Expression of a V. cholerae or S. mutans SAS homolog in E. coli is toxic in the absence of SpoT-mediated (p)ppGpp hydrolysis (19, 21) , supporting the theory that production of (p)ppGpp in the absence of a functional hydrolase is deleterious. In addition, deletion of the respective SAS homologs largely abolishes the slow-growth phenotypes of ⌬relA strains of S. mutans, E. faecalis, and B. subtilis (17) (18) (19) (20) , which, like M. tuberculosis ⌬rel Mtb , lack the only known enzyme capable of hydrolyzing (p)ppGpp. These data suggest that in S. mutans, E. faecalis, and B. subtilis, the slow growth of the ⌬relA mutant is due to the lack of (p)ppGpp hydrolase activity in the presence of (p)ppGpp synthesis.
With these data in mind, we have also reported the first investigations into the M. tuberculosis SAS homolog, rv1366. Interestingly, another important finding from our experiments is that a ⌬rv1366 strain exhibited WT rates of growth in liquid shaking cultures, on plates, and in biofilms as well as WT levels of virulence in the mouse model of infection. This indicates that under the conditions we tested and during pathogenesis in the mouse model, Rel Mtb is the main producer of (p)ppGpp. Deletion of rv1366 had no effect on the phenotypes of the ⌬rel Mtb strain, demonstrating that, unlike in other bacteria, the presence of an intact M. tuberculosis SAS homolog allele was not a source of toxicity in strains lacking Rel Mtb -mediated (p)ppGpp hydrolysis. Therefore, the question regarding the role of Rv1366 in M. tuberculosis remains unanswered. Murdeshwar et al. recently reported a study of the M. smegmatis SAS homolog, which they term MS_RHII-RSD because, unlike the M. tuberculosis homolog, MS_RHII-RSD encodes an amino-terminal RNase HII domain (41) . The authors show that a small amount of (p)ppGpp is produced in an M. smegmatis ⌬rel Msm mutant that is dependent on MS_RHII-RSD; however, the importance of this activity for survival has not been explored. Interestingly, the authors were unable to detect (p)ppGpp synthetase activity in vitro using the region of MS_RHII-RSD with homology to Rv1366, raising the possibility that MS_RHII-RSD has evolved functions distinct from those of Rv1366.
In summary, our data point toward a Goldilocks model of (p)ppGpp levels in mycobacteria, where too little (p)ppGpp is harmful for the bacteria in certain situations, like chronic infection, and too much is always deleterious. Recent antibiotic development efforts aim to target Rel Mtb (p)ppGpp synthetase activity as a therapeutic option (42, 43) . We propose that tipping the balance of (p)ppGpp levels in the other direction by inhibiting (p)ppGpp hydrolysis is also an attractive approach to targeting M. tuberculosis. Our data imply that if we were to inhibit (p)ppGpp hydrolysis with an antibiotic, mutants that develop resistance by abolishing (p)ppGpp production would be unable to persist in the host. Our findings would also apply to other bacteria that require a balance of (p)ppGpp production.
